Thursday - December 26, 2024
House Oversight & Accountability Committee Issues Testimony From Optum Rx CEO Conway
August 04, 2024
WASHINGTON, Aug. 4 -- The House Oversight and Accountability Committee released the following written testimony by Optum Rx CEO Patrick Conway from a July 23, 2024, hearing entitled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability":

* * *

Chairman Comer, Ranking Member Raskin, and Members of the Committee:

I am Dr. Patrick Conway, CEO of Optum Rx, a part of UnitedHealth Group. I apprecia . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products